• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2刺突糖蛋白与人血管紧张素转换酶2受体之间的关键相互作用

Critical Interactions Between the SARS-CoV-2 Spike Glycoprotein and the Human ACE2 Receptor.

作者信息

Taka Elhan, Yilmaz Sema Z, Golcuk Mert, Kilinc Ceren, Aktas Umut, Yildiz Ahmet, Gur Mert

机构信息

Department of Mechanical Engineering, Istanbul Technical University (ITU), 34437 Istanbul, Turkey.

Physics Department, University of California, Berkeley, California 94720-3220, United States.

出版信息

J Phys Chem B. 2021 Jun 3;125(21):5537-5548. doi: 10.1021/acs.jpcb.1c02048. Epub 2021 May 12.

DOI:10.1021/acs.jpcb.1c02048
PMID:33979162
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects human cells by binding its spike (S) glycoproteins to angiotensin-converting enzyme 2 (ACE2) receptors and causes the coronavirus disease 2019 (COVID-19). Therapeutic approaches to prevent SARS-CoV-2 infection are mostly focused on blocking S-ACE2 binding, but critical residues that stabilize this interaction are not well understood. By performing all-atom molecular dynamics (MD) simulations, we identified an extended network of salt bridges, hydrophobic and electrostatic interactions, and hydrogen bonds between the receptor-binding domain (RBD) of the S protein and ACE2. Mutagenesis of these residues on the RBD was not sufficient to destabilize binding but reduced the average work to unbind the S protein from ACE2. In particular, the hydrophobic end of RBD serves as the main anchor site and is the last to unbind from ACE2 under force. We propose that blocking the hydrophobic surface of RBD via neutralizing antibodies could prove to be an effective strategy to inhibit S-ACE2 interactions.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)通过其刺突(S)糖蛋白与血管紧张素转换酶2(ACE2)受体结合来感染人类细胞,并引发2019冠状病毒病(COVID-19)。预防SARS-CoV-2感染的治疗方法大多集中在阻断S-ACE2结合,但稳定这种相互作用的关键残基尚未得到充分了解。通过进行全原子分子动力学(MD)模拟,我们确定了S蛋白的受体结合域(RBD)与ACE2之间存在一个由盐桥、疏水和静电相互作用以及氢键组成的扩展网络。对RBD上这些残基进行诱变不足以破坏结合,但降低了将S蛋白从ACE2上解离的平均功。特别是,RBD的疏水末端作为主要的锚定位点,在受力情况下是最后一个从ACE2上解离的。我们提出,通过中和抗体阻断RBD的疏水表面可能是抑制S-ACE2相互作用的有效策略。

相似文献

1
Critical Interactions Between the SARS-CoV-2 Spike Glycoprotein and the Human ACE2 Receptor.严重急性呼吸综合征冠状病毒2刺突糖蛋白与人血管紧张素转换酶2受体之间的关键相互作用
J Phys Chem B. 2021 Jun 3;125(21):5537-5548. doi: 10.1021/acs.jpcb.1c02048. Epub 2021 May 12.
2
Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.通过远端多碱性切割位点增强严重急性呼吸综合征冠状病毒2刺突蛋白与受体的结合
ACS Nano. 2020 Aug 25;14(8):10616-10623. doi: 10.1021/acsnano.0c04798. Epub 2020 Aug 4.
3
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.竞争性 SARS-CoV-2 血清学研究表明,大多数针对刺突受体结合域的抗体竞争与 ACE2 结合。
mSphere. 2020 Sep 16;5(5):e00802-20. doi: 10.1128/mSphere.00802-20.
4
Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2.木犀草素抑制严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)刺突蛋白与血管紧张素转化酶 2 的结合。
Phytother Res. 2023 Aug;37(8):3508-3521. doi: 10.1002/ptr.7826. Epub 2023 May 11.
5
Key residues of the receptor binding domain in the spike protein of SARS-CoV-2 mediating the interactions with ACE2: a molecular dynamics study.介导与ACE2相互作用的新冠病毒刺突蛋白受体结合域关键残基:一项分子动力学研究
Nanoscale. 2021 May 27;13(20):9364-9370. doi: 10.1039/d1nr01672e.
6
Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.探究 SARS-CoV-2 P.1 变体刺突蛋白与人 ACE2 受体增强结合的结构基础。
J Cell Biochem. 2022 Jul;123(7):1207-1221. doi: 10.1002/jcb.30276. Epub 2022 May 27.
7
Potential use of the S-protein-Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019.S 蛋白-血管紧张素转化酶 2 结合途径在治疗 2019 年冠状病毒病中的潜在应用。
Front Public Health. 2022 Nov 28;10:1050034. doi: 10.3389/fpubh.2022.1050034. eCollection 2022.
8
All-Atom Simulations of Human ACE2-Spike Protein RBD Complexes for SARS-CoV-2 and Some of its Variants: Nature of Interactions and Free Energy Diagrams for Dissociation of the Protein Complexes.用于 SARS-CoV-2 及其一些变体的人 ACE2-刺突蛋白 RBD 复合物的全原子模拟:相互作用的本质和蛋白复合物解离的自由能图谱。
J Phys Chem B. 2022 Jul 28;126(29):5375-5389. doi: 10.1021/acs.jpcb.2c00833. Epub 2022 Jul 14.
9
Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.人类针对 SARS-CoV-2 刺突蛋白受体结合域的中和抗体的结构基础。
Microbiol Spectr. 2021 Oct 31;9(2):e0135221. doi: 10.1128/Spectrum.01352-21. Epub 2021 Oct 13.
10
Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms.ACE2-严重急性呼吸系统综合征冠状病毒 2/严重急性呼吸系统综合征冠状病毒刺突蛋白界面的动力学揭示了独特的机制。
Sci Rep. 2020 Aug 26;10(1):14214. doi: 10.1038/s41598-020-71188-3.

引用本文的文献

1
5-Aminolevulinic Acid Phosphate as an Immune System Enhancer Along with Vaccination Against SARS-CoV-2 Virus Infection: An Open-Label, Randomized Pilot Study.5-氨基乙酰丙酸磷酸酯作为一种免疫系统增强剂联合抗SARS-CoV-2病毒感染疫苗接种:一项开放标签、随机试点研究。
Life (Basel). 2025 Jun 13;15(6):953. doi: 10.3390/life15060953.
2
Biophysics of SARS-CoV-2 spike protein's receptor-binding domain interaction with ACE2 and neutralizing antibodies: from computation to functional insights.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白受体结合域与血管紧张素转换酶2(ACE2)及中和抗体相互作用的生物物理学:从计算到功能见解
Biophys Rev. 2025 Mar 8;17(2):309-333. doi: 10.1007/s12551-025-01276-z. eCollection 2025 Apr.
3
The Three-Dimensional Reference Interaction Site Model Approach as a Promising Tool for Studying Hydrated Viruses and Their Complexes with Ligands.
三维参考相互作用位点模型方法作为研究水合病毒及其与配体复合物的有前途的工具。
Int J Mol Sci. 2024 Mar 26;25(7):3697. doi: 10.3390/ijms25073697.
4
Autoimmune diseases of the spine and spinal cord.脊柱和脊髓的自身免疫性疾病。
Neuroradiol J. 2024 Jun;37(3):285-303. doi: 10.1177/19714009231187340. Epub 2023 Jul 3.
5
Novel Inhibitory Role of Fenofibric Acid by Targeting Cryptic Site on the RBD of SARS-CoV-2.新型降脂药非诺贝特通过靶向新冠病毒 RBD 隐匿表位发挥抑制作用
Biomolecules. 2023 Feb 14;13(2):359. doi: 10.3390/biom13020359.
6
Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation.运用计算模型研究了 5 种突变对 ACE2 受体结构的影响,及其与 SARS-CoV-2 一些新兴变异株感染性和毒力的相关性,结果提示了结合亲和力失调的机制。
Chem Biol Interact. 2022 Dec 1;368:110244. doi: 10.1016/j.cbi.2022.110244. Epub 2022 Nov 3.
7
Probing Mechanisms of Binding and Allostery in the SARS-CoV-2 Spike Omicron Variant Complexes with the Host Receptor: Revealing Functional Roles of the Binding Hotspots in Mediating Epistatic Effects and Communication with Allosteric Pockets.探究 SARS-CoV-2 刺突奥密克戎变异株复合物与宿主受体结合和变构的机制:揭示结合热点在介导上位效应和与变构口袋通讯中的功能作用。
Int J Mol Sci. 2022 Sep 29;23(19):11542. doi: 10.3390/ijms231911542.
8
Omicron BA.1 and BA.2 variants increase the interactions of SARS-CoV-2 spike glycoprotein with ACE2.奥密克戎 BA.1 和 BA.2 变异体增加了 SARS-CoV-2 刺突糖蛋白与 ACE2 的相互作用。
J Mol Graph Model. 2022 Dec;117:108286. doi: 10.1016/j.jmgm.2022.108286. Epub 2022 Aug 4.
9
The Biological Properties of the SARS-CoV-2 Cameroon Variant Spike: An Intermediate between the Alpha and Delta Variants.严重急性呼吸综合征冠状病毒2喀麦隆变体刺突蛋白的生物学特性:阿尔法变体和德尔塔变体之间的中间类型
Pathogens. 2022 Jul 20;11(7):814. doi: 10.3390/pathogens11070814.
10
In silico analysis of SARS-CoV-2 spike protein N501Y and N501T mutation effects on human ACE2 binding.基于 SARS-CoV-2 刺突蛋白 N501Y 和 N501T 突变对人 ACE2 结合影响的计算机分析。
J Mol Graph Model. 2022 Nov;116:108260. doi: 10.1016/j.jmgm.2022.108260. Epub 2022 Jul 1.